Your browser doesn't support javascript.
loading
Postprandial Plasma Lipidomics Reveal Specific Alteration of Hepatic-derived Diacylglycerols in Nonalcoholic Fatty Liver Disease.
Velenosi, Thomas J; Ben-Yakov, Gil; Podszun, Maren C; Hercun, Julian; Etzion, Ohad; Yang, Shanna; Nadal, Cathy; Haynes-Williams, Vanessa; Huang, Wen-Chun A; González-Hódar, Lila; Brychta, Robert J; Takahashi, Shogo; Akkaraju, Vikas; Krausz, Kristopher W; Walter, Mary; Cai, Hongyi; Walter, Peter J; Muniyappa, Ranganath; Chen, Kong Y; Gonzalez, Frank J; Rotman, Yaron.
Afiliación
  • Velenosi TJ; Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland.
  • Ben-Yakov G; Liver and Energy Metabolism Section, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland; Liver Diseases Branch, NIDDK, NIH, Bethesda, Maryland.
  • Podszun MC; Liver and Energy Metabolism Section, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland; Liver Diseases Branch, NIDDK, NIH, Bethesda, Maryland.
  • Hercun J; Liver Diseases Branch, NIDDK, NIH, Bethesda, Maryland.
  • Etzion O; Liver Diseases Branch, NIDDK, NIH, Bethesda, Maryland.
  • Yang S; Nutrition Department, NIH Clinical Center, Bethesda, Maryland.
  • Nadal C; Liver Diseases Branch, NIDDK, NIH, Bethesda, Maryland.
  • Haynes-Williams V; Liver Diseases Branch, NIDDK, NIH, Bethesda, Maryland.
  • Huang WA; Liver Diseases Branch, NIDDK, NIH, Bethesda, Maryland.
  • González-Hódar L; Liver and Energy Metabolism Section, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland; Liver Diseases Branch, NIDDK, NIH, Bethesda, Maryland.
  • Brychta RJ; Diabetes, Endocrinology, and Obesity Branch, NIDDK, NIH, Bethesda, Maryland.
  • Takahashi S; Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland.
  • Akkaraju V; Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland.
  • Krausz KW; Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland.
  • Walter M; Clinical Laboratory Core, NIDDK, NIH, Bethesda, Maryland.
  • Cai H; Clinical Mass Spectrometry Core, NIDDK, NIH, Bethesda, Maryland.
  • Walter PJ; Clinical Mass Spectrometry Core, NIDDK, NIH, Bethesda, Maryland.
  • Muniyappa R; Diabetes, Endocrinology, and Obesity Branch, NIDDK, NIH, Bethesda, Maryland.
  • Chen KY; Diabetes, Endocrinology, and Obesity Branch, NIDDK, NIH, Bethesda, Maryland.
  • Gonzalez FJ; Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health (NIH), Bethesda, Maryland.
  • Rotman Y; Liver and Energy Metabolism Section, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, Maryland; Liver Diseases Branch, NIDDK, NIH, Bethesda, Maryland. Electronic address: rotmany@niddk.nih.gov.
Gastroenterology ; 162(7): 1990-2003, 2022 06.
Article en En | MEDLINE | ID: mdl-35283114
ABSTRACT
BACKGROUND &

AIMS:

Hepatic energy metabolism is a dynamic process modulated by multiple stimuli. In nonalcoholic fatty liver disease (NAFLD), human studies typically focus on the static fasting state. We hypothesized that unique postprandial alterations in hepatic lipid metabolism are present in NAFLD.

METHODS:

In a prospective clinical study, 37 patients with NAFLD and 10 healthy control subjects ingested a standardized liquid meal with pre- and postprandial blood sampling. Postprandial plasma lipid kinetics were characterized at the molecular lipid species level by untargeted lipidomics, cluster analysis, and lipid particle isolation, then confirmed in a mouse model.

RESULTS:

There was a specific increase of multiple plasma diacylglycerol (DAG) species at 4 hours postprandially in patients with NAFLD but not in controls. This was replicated in a nonalcoholic steatohepatitis mouse model, where postprandial DAGs increased in plasma and concomitantly decreased in the liver. The increase in plasma DAGs appears early in the disease course, is dissociated from NAFLD severity and obesity, and correlates with postprandial insulin levels. Immunocapture isolation of very low density lipoprotein in human samples and stable isotope tracer studies in mice revealed that elevated postprandial plasma DAGs reflect hepatic secretion of endogenous, rather than meal-derived lipids.

CONCLUSIONS:

We identified a selective insulin-related increase in hepatic secretion of endogenously derived DAGs after a mixed meal as a unique feature of NAFLD. DAGs are known to be lipotoxic and associated with atherosclerosis. Although it is still unknown whether the increased exposure to hepatic DAGs contributes to extrahepatic manifestations and cardiovascular risk in NAFLD, our study highlights the importance of extending NAFLD research beyond the fasting state.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Insulinas / Enfermedad del Hígado Graso no Alcohólico Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Gastroenterology Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Insulinas / Enfermedad del Hígado Graso no Alcohólico Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Gastroenterology Año: 2022 Tipo del documento: Article